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Abstract
Cancer cells depend on glucose metabolism via glycolysis as a primary energy source,
despite the presence of oxygen and fully functioning mitochondria, in order to promote
growth, proliferation and longevity. Glycolysis relies upon NAD+ to accept electrons in the
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) reaction, linking the redox state of
the cytosolic NAD+ pool to glycolytic rate. The free cytosolic NAD+/NADH ratio is involved in
over 700 oxidoreductive enzymatic reactions and as such, the NAD+/NADH ratio is regarded
as a metabolic readout of overall cellular redox state. Many experimental techniques that
monitor or measure total NAD+ and NADH are unable to distinguish between protein-bound
and unbound forms. Yet total NAD+/NADH measurements yield little information, since it is
the free forms of NAD+ and NADH that determine the kinetic and thermodynamic influence
of redox potential on glycolytic rate. Indirect estimations of free NAD+/NADH are based on
the lactate/pyruvate (L/P) ratio at chemical equilibrium, but these measurements are often
undermined by high lability. To elucidate the sensitivity of the free NAD+/NADH ratio to
changes in extracellular substrate, an in silico model of hepatocarcinoma glycolysis was
constructed and validated against in vitro data. Model simulations reveal that over experi-
mentally relevant concentrations, changes in extracellular glucose and lactate concentration
during routine cancer cell culture can lead to significant deviations in the NAD+/NADH ratio.
Based on the principles of chemical equilibrium, the model provides a platform from which
experimentally challenging situations may be examined, suggesting that extracellular sub-
strates play an important role in cellular redox and bioenergetic homeostasis.
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Introduction
Cellular bioenergetics describe the processes that generate energy in the form of ATP within
the cell, achieved primarily via aerobic and anaerobic glycolysis, pyruvate and fatty acid oxida-
tion, and oxidative phosphorylation within the mitochondria [1,2]. When glycolysis is coupled
to oxidative phosphorylation, the NADH reducing equivalents produced in the cytosol by glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH) are shuttled to the mitochondrial matrix
where they are consumed by the respiratory chain. In the absence of oxygen, when mitochon-
dria are unable to recycle the NADH to NAD+, lactate dehydrogenase provides an alternate
means of oxidizing NADH to NAD+ to facilitate anaerobic glycolysis [3]. Tumours and
highly-proliferating cells can show increased uptake of glucose, favouring glycolytic produc-
tion of lactate, despite the presence of oxygen and fully functioning mitochondria [4]. The pro-
cess of aerobic glycolysis under these conditions is also known as the Crabtree Effect, which is
inefficient at producing ATP compared to the complete oxidation of glucose coupled to oxida-
tive phosphorylation in terms of stoichiometric conversion of glucose to ATP [5]. However,
the glycolytic rate can be considerably higher than oxidative respiration, and it has been sug-
gested that this results in total ATP synthesis that is comparable over any given time, for either
route of glucose metabolism [6]. Aerobic glycolysis in tumours and proliferating cells is recog-
nised as an adaptive mechanism to facilitate rapid ATP production, aid survival and allow cells
to thrive in the tumour microenvironment, and also to meet the elevated levels of biosynthesis
required to support uncontrolled proliferation [7]. In turn, proliferating cells have a higher
demand for reducing equivalents, in the form of NADH, which contributes to the NAD+/
NADH ratio [8]. Therefore, an inextricable link exists between aerobic glycolytic rate and free
NAD+/NADH redox state.
Current in vitro techniques for investigating the NAD+ pool redox state are only capable of
measuring total NAD+ and NADH without discriminating between free and protein-bound
forms [9]. This is problematic, as only free NAD+/NADH regulate cellular redox state, limiting
the insight that can be gleaned from the total NAD+/NADHmeasurement. Free NAD+/
NADHmay be estimated or derived via: (i) exploitation of the lactate/pyruvate (L/P) ratio at
equilibrium [10]; (ii) using hyperpolarised glucose [11]; or (iii) using genetically encoded sen-
sors (SoNAR) [12]. Estimation of the free NAD+/NADH ratio using the L/P ratio is the most
widely used approach, founded on the principles of chemical equilibrium, i.e., when the con-
version between pyruvate + NADH and lactate + NAD+ is at equilibrium, the free NAD+/
NADH ratio can be calculated by the following equation:
½NADþ�
½NADH�
¼ Keq �
½pyruvate�
½lactate�
; ð1Þ
where,
Keq ¼
½pyruvateeq�½NADHeq�½H
þ�
½lactateeq�½NAD
þ
eq�
¼ 1:11� 10 11: ð2Þ
To use this method, the accurate definition of the equilibrium status for the conversion of
the L/P ratio is crucial to correctly estimate the NAD+/NADH ratio [9]. Specifically, studies
which assume the conversion is at equilibrium, whilst failing to confirm how close it is, can
result in estimated ratios that are 1 to 2 orders of magnitude away from the true value. This is
because the mass action reaction quotient (Q) at near equilibrium can differ between 1 and 2
orders of magnitude [13–19]. When Q = Keq, the forward and reverse rates of conversion are
equal and there is no net loss or gain of lactate. However, when Q< Keq, the reaction favours
formation of lactate and similarly, when Q> Keq, the reaction favours formation of pyruvate
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[9]. In cultured cancer cells, the conversion is predominantly from pyruvate to lactate, due to
the rapid disposal of lactate via monocarboxylate transporters (MCTs) located on the plasma
membrane [20,21]. This is a function of the high glycolytic rates found in cancer cells, which
results in excessive production of pyruvate and NADH that is beyond the metabolic capacity
of mitochondrial shuttles and pyruvate dehydrogenase [22]. To utilise the L/P ratio conversion
to estimate free NAD+/NADH, one must force chemical equilibrium in vitro by elevating
extracellular lactate concentrations between 16 and 22 mM [9]. However, in doing so, glucose
consumption is seen to significantly reduce [9], thus demonstrating that the manipulation of
extracellular lactate concentrations artificially alters the state of cellular lactate equilibrium
while simultaneously perturbing glucose and energy metabolism.
One way of determining glycolytic rate in vitro is by extracellular flux analysis (EFA), which
is relatively high throughput and experimentally inexpensive [23–25]. This method quantifies
cellular respiration in the form of oxygen consumption rate (OCR) and extracellular acidifica-
tion rate (ECAR). ECAR can be used as a measure of glycolytic rate when it is assumed that
lactic acid, the terminal product of glycolysis, dissociates in the extracellular environment to a
proton (H+) and lactate anion at physiological pH. Recently, the significance of respiratory
contributions to ECAR has been highlighted, illustrating that the release of CO2 via oxidative
phosphorylation can lead to the formation and dissociation of carbonic acid (H2CO3), ampli-
fying and potentially distorting the ECAR output when used to assess glycolytic rate [26]. For-
tunately, the proportion of respiratory acidification and glycolytic-only acidification can be
easily calculated using the extracellular media buffering power (BP) [27]. This differentiation
of acidification sources is necessary, as different cell types under different culture conditions
may acidify the extracellular environment almost entirely via glycolysis or respiration [27].
Therefore, glycolytic proton production rate (PPRgly) is considered a more accurate represen-
tation of glycolytic rate compared to ECAR [27]. Current in silicomodels that focus specifically
on hepatocellular bioenergetics in combination with EFA, are lacking in metabolic network
depth and, as a result, authors tend to mathematically express glycolytic rate as pyruvate-to-
lactate flux, rather than proton release into an extracellular environment, omitting respiratory
contributions to ECAR altogether [27].
This study describes the construction, parameterisation and validation of an in silicomodel
of hepatocarcinoma cell glycolysis used to investigate: (i) the sensitivity of the NAD+/NADH
redox ratio to perturbations in extracellular lactate and glucose concentrations; and (ii)
changes to GAPDH and LDH enzyme fluxes during variations in the extracellular substrate.
The model described, captures the rapid binding and unbinding between protons and metal
ions with all modelled biochemical species. This allows for the computation of the dynamic
changes in pH from the total proton stoichiometry, which is crucial when simulating in vitro
PPRgly as a function of H
+/lactate efflux into an extracellular environment. The model is vali-
dated against in vitro hepatocarcinoma EFA and NAD+-ATP data, to confirm the ability of the
model to recreate the relationship between the two outputs. The HepG2 cell line was used due
to the substantial number of studies that utilise these cells as a hepatic in vitromodel for the
study of bioenergetic toxicity [26,27]. Furthermore, this immortalized cell line was favoured
over primary cells, as cancer cells are renowned for utilising the glycolytic pathway for the gen-
eration of cellular energy (ATP) over oxidative phosphorylation as a result of the Warburg
effect, facilitating the study of ECAR as a function of glycolytic flux [5,27]. The two-point vali-
dation allows for changes in glycolytic rate as a function of NAD+/NADH perturbations to be
explored. This approach aims to provide a platform from which aerobic glycolytic flux as a
function of experimentally challenging situations may be investigated.
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Materials and methods
In silico
Model development. The mathematical model of hepatic glycolysis consists of 26 state
variables, 14 enzyme-mediated reactions and two transport fluxes, occurring in two compart-
ments: cytoplasm and extracellular space (Fig 1). Variable and reaction abbreviations are given
in Tables 1 and 2 respectively. Reaction and transporter kinetics are modelled using kinetic
terms and parameters sourced from the literature, or by fitting to experimental flux data. A
comprehensive list of all kinetic terms can be found in the S1 Supporting Information. Flux
units for the model are given as mMmin-1.
Fig 1. Schematic of the human hepatic bioenergetic model. The biochemical model comprises two compartments:
cytoplasm and extracellular space. Glycolytic enzymes are shown in purple, transporter reactions are depicted as blue
rectangles and additional reactions are portrayed in orange. Reaction descriptions can be found in Table 2. See S1
Supporting Information for additional information.
https://doi.org/10.1371/journal.pone.0207803.g001
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Modelling pH-dependent enzyme kinetics and reaction equilibria: BISEN
The hepatic glycolysis model was constructed in MATLAB, utilising the Biochemical Simula-
tion Environment (BISEN) suite [28]. BISEN is an open-source tool that assists in generating
sets of differential equations for simulating biochemical systems, accounting for dynamic pro-
ton and metal ion buffering, thermodynamics and reaction equilibria. Detailed instructions on
how to use BISEN have been previously published [28]. Briefly, the state variables refer to the
biochemical reactants within the model which are the sum of its interconvertible biochemical
species. For example, ATP is a reactant that represents the sum of its related species: ATP4-,
HATP3-, MgATP2- etc. By accounting for the rapid interconversion of all species with metal
ions and protons, the differences in state depending upon the pH can be modelled, whilst
accounting for a complete proton stoichiometry. Each biochemical equation has its own asso-
ciated equilibrium constant and the standard-state free energy of reaction, ΔrG0, that is inde-
pendent of pH yet dependent upon changes in temperature and ionic strength. Overall, this
allows favorability of a reaction to change as a result of a pH change [29].
Kinetic equations and parameters
Transporter and glycolysis enzyme reaction equations, as well as initial parameter estimates,
are all sourced from the literature (Table 2), predominantly from a comprehensive model of
human hepatic glucose metabolism from Koenig et al. [30]. Additional reaction equations and
parameters are based on experimental data from the literature or described here in this paper.
All literature sourced parameter values can be found in the S1 Supporting Information. For
model alignment with experimental data, certain model parameters were adjusted using
unconstrained nonlinear optimization (Nelder-Mead simplex algorithm), starting with an ini-
tial literature-based parameter estimate. All rate equations and parameters are liver specific
and can be found in the S1 Supporting Information along with their corresponding references.
Model simulations
Model simulations were produced via integration of the resulting ordinary differential equa-
tions (ODEs) (S1 Supporting Information) using the variable order stiff solver ode15s
(MATLAB). Compartment volumes were also set to mimic EFA by assigning the cytoplasm /
intracellular volume as the volume occupied by the 2.5 × 104 cells seeded per well, and the
extracellular volume as 200 μl for the total extracellular volume of each well used in the EFA.
In silico–in vitro PPRgly coupling
In silico PPRgly was simulated as a function of the MCT1 transport flux, JMCT1, expressed in
mMmin-1. Conversion from in silico transport flux of mMmin-1 to the in vitro PPRgly pmol
min-1 / μg protein measurement was accomplished using Eq 3. Note, this conversion equation
also includes normalization for experimental protein content, where PNF is the protein nor-
malization factor.
PPRgly ¼
JMCT1ð2� 10
3Þ
PNF
: ð3Þ
In vitro
Materials. All extracellular flux analysis consumables were purchased from Seahorse Bio-
sciences (North Billerica, MA, USA). HepG2 cells were purchased from the European Collec-
tion of Cell Cultures (ECACC, Salisbury, UK). Dulbecco’s modified media, Phosphate
Modelling changes in the NAD+/NADH ratio during cell culture
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Buffered Saline (PBS) and Rat tail Collagen I were purchased from Life Technologies (Paisley,
UK). All other reagents were purchased from Sigma Aldrich (Dorset, UK).
Cell culture. HepG2 cells were maintained in DMEM high-glucose media (glucose 25
mM) supplemented with foetal bovine serum (10% v/v), L-glutamine (2 mM), sodium pyru-
vate (1 mM) and HEPES (1 mM). Cells were incubated at 37˚C under humidified air contain-
ing 5% CO2. Cells were used up to passage 17.
Extracellular flux analysis assay. HepG2 cells were collected on the day of the experiment
by trypsinisation and then washed thrice with serum- and glucose-free media. The cells were
then plated onto a collagen coated (50 μg/ml in acetic acid 0.02 M) XFe 96-well cell culture
microplates (2.5 × 104 cells/well) overnight in 100 μl of high glucose (25 mM) cell culture
media. Before analysis, culture medium was removed from all wells and replaced with 175 μl of
unbuffered glucose free Seahorse Assay media, supplemented with sodium pyruvate (1%v/v)
and L-glutamate (1% v/v), pre-warmed to 37˚C. Cells were then incubated in a CO2 free incuba-
tor at 37˚C for 1 h. Before rate measurement, the XFe96 Instrument (Seahorse biosciences,
North Billerica, MA) mixed the assay media in each well for 10 min, allowing the oxygen partial
pressure to equilibrate. The oxygen consumption rate (OCR) and extracellular acidification
rate (ECAR) were measured simultaneously thrice, establishing a baseline rate. For each
Table 1. Model biochemical reactants including their corresponding abbreviations (Fig 1), allocated compartment and initial concentration.
Variable Abbreviation Compartment Initial
Concentration (mM)
Glucose GLC Cytoplasm 5.000
ATP ATP Cytoplasm 2.800
ADP ADP Cytoplasm 0.800
Glucose-6-phosphate G6P Cytoplasm 0.120
Fructose-6-phosphate F6P Cytoplasm 0.005
Inorganic phosphate Pi Cytoplasm 5.000
Fructose-1,6-phosphate F16P Cytoplasm 0.020
1,3-bisphospho-glycerate BPG Cytoplasm 0.300
Fructose-2,6-phosphate F26P Cytoplasm 0.004
Dihydroxyacetone-phosphate DHAP Cytoplasm 0.300
Glyceraldehyde-phosphate GHAP Cytoplasm 0.100
NAD NAD Cytoplasm 1.220
NADH NADH Cytoplasm 0.00056
2-phospho-D-glycerate PG2 Cytoplasm 0.030
3-phospho-D-glycerate PG3 Cytoplasm 0.270
Phosphoenolpyruvate PEP Cytoplasm 0.150
Pyruvate PYR Cytoplasm 0.100
Lactate LAC Cytoplasm 0.500
Protons H Cytoplasm 6.8 (pH)
Magnesium ions Mg Cytoplasm 5.000
Potassium ions K Cytoplasm 8.000
Glucose GLCe Extracellular 5.000
Lactate LACe Extracellular 0.000
Protons He Extracellular 7.4 (pH)
Magnesium ions Mge Extracellular 0.000
Potassium ions Ke Extracellular 0.000
Extracellular variables are distinguished from cytoplasm variables using subscript “e”.
https://doi.org/10.1371/journal.pone.0207803.t001
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measurement there was a 3 min mix followed by 3 min wait time to restore normal oxygen ten-
sion and pH in the transient microenvironment surrounding the cells. Glucose injections (0.1–
25 mM) of 25 μl occurred at the end of the basal measurement cycles at 16 min, followed by 10
further measurements. The overall assay duration was 95 min for each of the n = 4 experimental
repeats.
BCA protein quantification assay. Post extracellular flux analysis, assay medium was
removed from all wells before the addition of 50 μl of Somatic cell ATP releasing agent
(Sigma-Aldrich) to each well and the plate was carefully shaken (1 min, 300 RPM). A standard
curve was prepared using a BCA stock (2 mg BCA/ml in ATP releasing agent). Working
reagent (WR) was prepared by adding 50 parts bicinchoninic acid to 1 part copper sulphate.
5 μl of cell lysate was plated into a clear 96 well plate followed by addition of 200 μl of WR
before incubation (37˚C, for 30 min). The absorbance was then measured at 580 nm on a Lab-
systems Multiskan plate reader. Protein content was then extrapolated from the standard
curve. Protein concentrations were then used to normalise the extracellular flux data, giving
overall rates of ECAR and OCR as mpHmin-1 well protein-1 and pmol min-1 well protein-1,
respectively.
Buffering power. EFA assay media buffering capacity was measured at 37 oC using a pH
probe. Hydrochloric acid (HCl) (0.1 M) was charged in 6 x 20 μl aliquots to 10 ml of assay
media, while changes in pH were recorded. Media buffering power was calculated from the
gradient of the line of best fit after plotting the change in pH vs nmol H+ added per 2 μl [31].
PPRgly calculations. PPRgly was calculated from the ECAR measurements following the
methodology of Mookerjee et. al (26,27). Briefly, ECAR was measured in units of mpH/min/
well protein-1, representing respiratory and glycolytic contributions to acidification. The total
proton production rate, PPRtot (pmol H
+/min/μg protein), was calculated using Eq (4).
PPRtot ¼
ECAR
BP
: ð4Þ
Table 2. Model enzyme-mediated reactions including abbreviations and descriptions (Fig 1).
Reaction Abbreviation Description
Glucokinase GLK GLC + ATP! ADP + G6P + H
Glucose-6-phosphatase G6Pase G6P + H2O!G6P+ Pi
Phosphoglucose isomerase PGI G6P⇋ F6P
Phosphofructokinase PFK F6P + ATP! F16P + ADP + H
Fructose-1,6-bisphosphatase FBP1 F16P + H2O! F6P + Pi
Aldolase ALD F6P⇋ DHAP + GAPH
Triosephosphate isomerase TPI DHAP⇋ GAPH
Glyceraldehyde-3-Phosphate dehydrogenase GAPDH GAPH + Pi + NAD+⇋ BPG + NADH + H
Phosphoglycerate kinase PGK BPG + 2 ADP⇋ PG3 + 2 ATP
Phosphoglycerate mutase 1 PGM PG3⇋ PG2
Enolase / phosphopyruvate hydratase ENO PG2⇋ PEP
Pyruvate Kinase PYK PEP + 2 ADP + H⇋ PYR + 2 ATP
Lactate dehydrogenase LDH PYR + NADH + H⇋ LAC + NAD
Glucose Storage (Glycogenolysis) FD GLC! Ø
Glut-2-transporter GLUT2 GLCe⇋ GLC
Monocarboxylate transporter 1 MCT1 LAC+ H⇋ LACe + He
Single-headed reaction arrows indicate irreversible reactions and double arrows indicate reversible reactions. Full details of each reaction / transporter along with their
corresponding parameter values can be found in the S1 Supporting Information.
https://doi.org/10.1371/journal.pone.0207803.t002
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The respiratory contributions to PPR, PPRresp (pmol H
+/min/μg protein), were calculated
using Eq 5, where pK1 is the overall pKa for CO2(aq) + H2O!HCO3
- = 6.093, max H+/O2 = 1
is the derived acidification for the metabolic transformation of glucose oxidation, the average
total amount of oxygen consumption, denoted OCRtot, is equal to 17.78 pmol O2/min/μg
protein for 5 mM over 10 measurements and non-respiratory oxygen consumption denoted
OCRrot, is equal to 5.17 pmol O2/min/μg protein. Thus,
PPRresp ¼
10
pH pK1
1þ 10pH pK1
� �
maxHþ
O
2
� �
OCRtot   OCRrotð Þ: ð5Þ
Finally, using Eq (6), PPRgly was calculated by subtracting respiratory acidification contri-
butions from the total proton production rate:
PPRgly ¼ PPRtot   PPRresp: ð6Þ
Statistical analysis
Statistical significance was ascertained using Prism 5 software via a one-way ANOVA, with
values expressed as a mean ± standard deviation (S.D) taken from four independent experi-
ments (n = 4 experimental repeats).
Results and discussion
Extracellular flux analysis
The effects of changes in extracellular glucose concentration (0–25 mM) on PPRgly and OCR
for HepG2 cells were examined (Fig 2).
Prior to EFA, the cells were starved for 60 minutes in glucose-free media. Glucose was rein-
troduced after 16 minutes of EFA, stimulating increases in PPRgly ratio and decreases in OCR,
for all concentrations of glucose (Fig 2). These results suggest that the introduction of extracel-
lular glucose increases glycolytic energy metabolism, while diminishing respiratory energy
production. An increase in glycolytic energy metabolism, facilitates ATP generation from glu-
cose at a faster rate than oxidative phosphorylation. The ability of carcinoma cell lines, includ-
ing HepG2, to exhibit this phenomena is well characterized and has been reported previously
[4,32]. It is common practice to use high-glucose (25 mM) during routine cell culture. Fig 2
highlights how a high-glucose extracellular environment can influence cellular energy metabo-
lism, illustrating that 25 mM glucose can yield up to a 7-fold increase in glycolytic-based
energy metabolism when compared to a physiologically relevant extracellular glucose concen-
tration (5 mM). In this instance, while glycolytic-based metabolism is primarily responsible
for energy production, deducting respiratory contributions to extracellular acidification is an
essential and facile endeavor for the sake of understanding the cellular bioenergetic output.
Sensitivity analysis
Testing the sensitivity of a metabolic model with respect to its parameters is a crucial way of
assessing its robustness. Variables that are most sensitive to parameter perturbation can be
identified by measuring subsequent changes in time-course simulations and accordingly, any
measurements or fluctuations in processes represented by these parameters must be carefully
considered. Sensitivity analysis may be presented in many forms depending upon the state of
the system. For this model, the relative change of the jth variable with respect to a -99% to
+400% change in the ith parameter was measured (Eq 7). Vj is defined as the j
th variable over
time. More specifically, V ibasej is the j
th variable with its base value; V ivalj is the j
th variable with a
Modelling changes in the NAD+/NADH ratio during cell culture
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perturbed value; with ival � [-99,400%] of its base value, ibase. Mean Vj(t) is denoted as VjðtÞ;
the mean value of the jth variable over the time course t � [0,300] min. Thus, our sensitivity
metric, X, is defined:
X ¼
max variable change
relative to
parameter change
¼ max
jV ivalj ðtÞ   V
ibase
j ðtÞj
V ibasej ðtÞ
ibase
jival   ibasej
 !
: ð7Þ
A value of X = 1 would signify that the absolute, relative change in the mean of the variable
over the time course is the same as the absolute, relative change in parameter. A parameter is
classed as mildly sensitive (MS) if X is between 1 and 10. A parameter is sensitive (S) if X> 10.
The sensitivity analysis results for the model are given in Fig 3. This analysis identified 8 key
sensitive parameters: phosphofructokinase (PFK) Vmax (MS); triosephosphate isomerase (TPI)
Keq (MS); dihydroxy-acetone phosphate (DHAP) Km (MS); glyceraldehyde dehydrogenase
(GAPDH) Keq (MS); KmNAD+ (MS); lactate dehydrogenase (LDH) Vmax (MS); MCT1 Keq
(S); and MCT1 Vmax (S). The two most sensitive parameters with respect to lactate, Keq and
Vmax for the MCT1 transporter, are plotted as a % mean change of its initial value in Fig 4.
With two out of three MCT1 transporter parameters registering as sensitive, parameter selec-
tion for this enzyme-mediated reaction must be carefully considered, especially when MCT1
transporter flux is to be used for simulating PPRgly.
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Fig 2. The effect of extracellular glucose on PPRgly and OCR.HepG2 cells were exposed to serial concentrations of glucose (0.1 to 25 mM) at
t = 16 minutes. PPRgly and OCR values are normalised by the values obtained prior to glucose exposure and are expressed as the PPRgly and
OCR ratios compared to zero glucose added. Measurements are an average of n = 4 experimental repeats.
https://doi.org/10.1371/journal.pone.0207803.g002
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Fig 4 shows the effects of changes in Vmax MCT1 and KeqMCT1 on intracellular lactate
concentrations. The initial parameter was altered from -99% to +400% in 21 iterations, as
shown with the 21 bars for each plot. Evidently, intracellular lactate concentration is more sen-
sitive to the MCT1 equilibrium constant than the Vmax. However, both parameters satisfy the
sensitive criteria threshold X> 10 (Fig 3).
Model parameterisation: Cytoplasmic lactate content
To accurately choose the values for the identified sensitive parameters, the model was fitted to
in vitro intracellular lactate concentration. Liu et al. measured the intracellular lactate concen-
tration of HepG2 cells during their study on the effects of miR-122 on pyruvate kinase [33].
Their data was used for comparison of the model simulations of the cytoplasm concentration
of lactate over an extended time course of 48 h. Parameter adjustments were performed using
unconstrained nonlinear optimization as described in the methods section, such that MCT1
Vmax and MCT1 Keq values were adjusted from 33 mMmin
-1 and 1, to 2.0×10−3mMmin-1
and 1.15×102 respectively (equilibrium constants are unitless) in Fig 5. Steady state cyto-
plasmic levels of lactate in the model, prior to parameter adjustment, were approximately
three times higher than in vitro amounts. A minor adjustment to the MCT1 Vmax parameter
provided a more comparable in vitro–in silico intracellular steady state concentration of lactate,
while simultaneously leaving other variable and flux steady state concentrations largely
unaltered.
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Model validation: Simulating EFA PPRgly and the NAD
+/ATP relationship
EFA PPRgly experimental data not used for the original parameterisation was used to validate
the model. The in vitro experiment consists of a 1440-min (24 h) incubation in a high glucose
environment (25 mM), followed by extracellular lactate and glucose removal during a 60-min
incubation in unbuffered media prior to EFA. Glucose is reintroduced at t = 1500 min after
the end of the glucose-free incubation, followed by 80 min of measurements. The model repli-
cated the EFA analysis data by generating the corresponding PPRgly profile for 7.5, 10 and 12.5
mM of glucose, using the MCT1 flux term (Fig 6). The model output was normalized to the
average protein content of the respective wells. The simulated PPRgly is in good accordance
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with experimental observations, with the model being able to accurately simulate PPRgly using
the MCT1 flux only, suggesting that lactate/H+ is likely responsible for glycolytic extracellular
acidification, which is in good agreement with the literature [34–36]. Furthermore, these simu-
lations implement the cell incubation and media change features that occur prior to EFA, dem-
onstrating the model’s ability to simulate extracellular changes that cannot be measured
experimentally, and predict how the system responds to such perturbations. Simulation of the
in vitro data inclusive of the incubation prior to EFA analysis provides confidence in the
robustness of the model and its output with respect to glycolytic rate.
Fig 7 shows further model validation by comparing in silicoNAD+/ATP ratio outputs with
experimental data [37]. NAD+ concentration in the cytoplasm depends on ATP concentration
in liver cells such that linear increases in ATP lead to linear increases in NAD+ [37]. Model
simulations mirror the experimentally observed positive correlation between ATP and NAD+.
Note, the experimental data used in this section of model validation represents estimated
NAD+ using the L/P derivation method, which may explain the slight discrepancy between the
model output and the data. Overall, the model’s ability to simulate glycolytic rate, while captur-
ing the essential dynamics between ATP and NAD+ concentration, demonstrates model fidel-
ity with respect to the simulation of these two experimental outputs.
Model predictions
NAD+/NADH redox state is sensitive to extracellular lactate and glucose concentra-
tion. The model predictions for the sensitivity of the NAD+/NADH ratio during changes in
extracellular substrates (glucose and lactate) are shown in Fig 8. Fig 8A shows the dynamic
NAD+/NADH time-course profiles for an experimentally relevant range of extracellular glu-
cose concentrations over a 120-min simulation. The model was first run to steady state (not
shown), followed by perturbations from 0 to 25 mM of extracellular glucose. Each line repre-
sents the percentage change in the NAD+/NADH ratio compared to no change in extracellular
Fig 5. Intracellular lactate concentration after 48 h: Model intracellular lactate concentration was aligned with
experimental data fromHepG2 cells after 48 h.Model 1 simulation represents the lactate concentration pre-
parameter adjustment with all model parameters obtained from the literature. Model 2 simulation represents post-
parameter adjustment.
https://doi.org/10.1371/journal.pone.0207803.g005
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glucose (black dashed line), where the initial conditions for the unperturbed simulations were
4.9 mM for extracellular glucose and 0.0012 mM for extracellular lactate. When extracellular
glucose concentration is less than 5 mM, the model predicts a continuous increase in the
NAD+/NADH ratio up to a maximum change of 4.8% at 120 min. Conversely, for concentra-
tions of glucose greater than 5 mM, the model predicts a decrease in the NAD+/NADH ratio
with a maximum decrease of 10.4% at 25 mM after 120 min. These model outputs suggest that,
during hypoglycaemic conditions (< 5 mM), the model favours hepatic glucose production as
opposed to utilisation, which would lead to a reduction in the concentration in NADH. During
elevated glucose exposure (> 5 mM), the model output predicts increased glycolytic glucose
utilisation, which is well documented experimentally (for every molecule of glucose metabo-
lised via glycolysis, there is a net gain in 2 ×NADHmolecules) [38]. Therefore, as extracellular
glucose concentrations increase, the glycolytic rate and NADH concentration increases, lead-
ing to a reduction in the NAD+/NADH ratio. The opposite is predicted when glucose is less
than 5 mM.
Fig 8B illustrates the dynamic time-course outputs in NAD+/NADH during perturbations
in extracellular lactate concentration from 0 to 40 mM over a 120-min simulation, represent-
ing the typical concentration range within a tumour microenvironment [39]. Following the
initial steady state, each line represents the post-perturbation percentage change in the NAD+/
NADH ratio compared to no change in extracellular lactate (black dashed line). As the
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concentration of extracellular lactate increases, the model predicts a continuous percentage
decrease in the NAD+/NADH with a maximum decrease of 44.2% at 120 min. From a chemi-
cal equilibrium perspective, increases in extracellular lactate will promote uptake of lactate via
the MCT1 which will in turn, alter Q to favour the conversion of lactate to pyruvate (when
Q> Keq) [40]. An increase in the conversion of lactate to pyruvate means an increase in
NADH and therefore a decrease in the NAD+/NADH ratio. Ultimately, simulations suggest
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Fig 7. Model validation.Model output was validated by simulating changes in NAD+ as a function of ATP perturbations. The model was run to steady state before
perturbing ATP concentrations. Experimental data was taken from Devin et. al [37].
https://doi.org/10.1371/journal.pone.0207803.g007
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that an increase in both extracellular substrates will favour the reduction of the NAD+/NADH
ratio by increasing the concentration of NADH though induction of glycolysis during elevated
extracellular glucose, and by alteration of the pyruvate to lactate conversion through Q during
elevated extracellular lactate exposure.
Extracellular glucose and lactate influences NAD+/NADH through GAPDH and LDH
fluxes. Glycolytic regulation of cytosolic NAD+/NADH is maintained through two key
enzymes: GAPDH and LDH. Perturbations in the reaction fluxes of these enzymes directly
affects the NAD+/NADH ratio within the model. Therefore, the sensitivity of these key
enzymes towards changes in the extracellular substrate environment was investigated. Fig 9
shows the resulting simulated changes in reaction fluxes for GAPDH and LDH during pertur-
bations in extracellular glucose (0 to 25 mM, top panel) and extracellular lactate (0 to 40 mM,
bottom panel) during a 120-minute simulation. Each line represents the percentage change in
the enzyme flux compared to no change in extracellular glucose (black dashed line), using the
same initial conditions as in Fig 8.
Simulations predict that for elevated extracellular glucose (> 5 mM), GAPDH and LDH
enzyme fluxes increase up to a maximum of 84% and 37% respectively. During diminished
extracellular glucose concentrations (< 5mM), the model predicts negative GAPDH and LDH
fluxes, with a maximum decrease of -40% and -8.8% respectively. Negative reaction fluxes
illustrate a switch in metabolic directionality whereby the reverse reaction governed by each
enzyme is favoured. Consequently, when extracellular glucose concentration is high (> 5
mM), the model predicts increased formation of NADH through accelerated GAPDH flux,
and increased NAD+ formation through accelerated LDH flux. While both NADH and NAD+
production is elevated, GAPDH is predicted to be more sensitive to extracellular glucose than
LDH, with simulations suggesting that GAPDH flux is more than twice as fast as LDH. This
results in a net increase in NADH, corresponding to the decreased NAD+/NADH ratio seen in
Fig 8.
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Fig 8. Extracellular substrate perturbations. Simulations of the resulting changes in NAD+/NADH ratio as a function of perturbations in extracellular glucose (A, 0 to
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The bottom panel in Fig 9 shows how changes in extracellular lactate concentration affects
GAPDH and LDH reaction flux. For all increased concentrations of extracellular lactate, simu-
lations predict negative reaction fluxes for GAPDH, with a maximum change of 318% after
120 minutes. For the same changes in extracellular lactate concentration, the model also pre-
dicts a negative reaction flux for LDH, with a maximum of 716% over 120 minutes. Negative
enzyme flux profiles suggest favouring of the production of NAD for GAPDH accompanied
by the favouring of production of NADH for LDH. Overall, during increases in extracellular
lactate concentration, the model predicts that there will again be a net increase in NADH con-
centration, given the differences in sensitivity between GAPDH and LDH.
It is unsurprising that increased extracellular lactate stimulates an increase in the reverse
LDH flux, as tumour cells growing under aerobic conditions can utilise lactate as an energy
source by uptake followed by conversion back to pyruvate, also known as metabolic symbiosis
[39]. Lactate as an energy source in this instance spares glucose, making it more readily avail-
able for hypoxic tumour cells, with oxidative tumour cells preferring lactate as a source of met-
abolic fuel [41]. Furthermore, model predictions are in good accordance with the literature,
which suggests that oxidation of lactate to pyruvate under these circumstances sustains NADH
production in order to mitigate tumour oxidative stress [42]. While glycolytic regulation in
general is complex, GAPDH is recognised as an important regulatory enzyme in living cancer
cells, suggesting that GAPDH exhibits the most positive control on glycolytic flux according to
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Fig 9. Extracellular substrate perturbations. Simulations of the resulting changes in GAPDH and LDH flux as a function of perturbations in extracellular glucose (0 to
25mM, top row panels) and lactate (0 to 40 mM, bottom row panels). Each simulation represents the percentage change in GAPDH and LDH flux compared to an
unperturbed simulation (black dashed line) over a 120-min period, with the perturbation of extracellular substrate occurring at 0 min. Time therefore represents time
post-perturbation.
https://doi.org/10.1371/journal.pone.0207803.g009
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metabolic control analysis [43]. GAPDH within the glycolytic pathway is regulated by ATP
and NAD+, and with respect to aerobic glycolysis, GAPDH is highly expressed, emphasising
its role in supporting the elevated demand for glycolysis [44]. Model simulations predict that
the NAD+/NADH ratio may be manipulated through changes in GAPDH and LDH flux, as a
function of perturbations in extracellular glucose and lactate.
Model considerations and applications
The model presented here extends the mathematical/computational representation of in vitro
EFA with regards to glycolytic rate. Other models such as the MITOsym, provide an outstand-
ing computational representation of EFA, boasting inclusion of both oxidative and respira-
tory-based bioenergetic processes [45]. However, the MITOsym model is a significantly
reduced representation of the bioenergetic portrait, aimed at capturing the key aspects of mito-
chondrial function in a whole cell environment [45]. In doing so, NADH is not explicitly mod-
elled, but instead inferred from utilisation of pyruvate. Moreover, glycolysis itself is captured
through a reduced set of ODEs, with ECAR computed using pyruvate-to-lactate flux (repre-
sentative of LDH) [45]. Here, glycolytic rate is modelled using the glycolytic pathway in its
entirety, including dynamic proton and metal ion buffering, thermodynamics and reaction
equilibria. In doing so, the model is able to represent glycolytic rate specifically in the form
that EFA measures it, i.e. PPRgly, using the MCT1 proton-lactate efflux process (Fig 6). More-
over, NAD+/NADH in this model is explicitly represented, capturing the relationship between
NAD+ and ATP (Fig 7). Therefore, the model presented here is better suited for simulating
and investigating glycolytic rate in the form of PPRgly. However, a caveat of this model is that
it does not include TCA or oxidative metabolism and therefore its output is limited to repre-
sent non-oxidative energy metabolism only. Furthermore, while Ca2+ is present as a variable
in the model, the omission of mitochondrial metabolism limits the models ability to explicitly
capture other important regulators of the cytosolic NAD+/NADH ratio, for example, how the
translation of cytosolic Ca2+ transients by the mitochondria results in transmission of NADH
from the mitochondria itself to the cytosol [46]. The model predicts that the availability of
extracellular substrates influences the NAD+/NADH ratio, particularly extracellular lactate
(Fig 8). This is informative as in vitro derivation of the NAD+/NADH ratio by forcing chemical
equilibrium using elevated concentrations of extracellular lactate could therefore lead to spuri-
ous estimations. Moreover, simulations predict that changes in GAPDH and LDH flux, as a
function of perturbations in extracellular substrate, significantly influence glycolytic rate and
the NAD+/NADH ratio (Fig 9). Indeed, the relationship between these enzymes and glycolytic
rate is strengthened in Fig 3, where the parameters Keq GAPDH and Vmax LDH score as mildly
sensitive with respect to PPRgly. The relationship between extracellular substrate and NAD
+/
NADH could be exploited, using the model to assist the design of experiments whereby extra-
cellular substrates are deliberately manipulated to yield variance in the NAD+/NADH ratio.
Such methods could perhaps be used to mimic inter-individual variation, metabolic disorders
or cellular metabolic variations. At the very least, these simulations, which are in accordance
with literature and in vitro outputs [10,41–43], suggest that the composition of extracellular
substrates during cancer cell culture should be considered carefully due to their potential influ-
ence on the cellular free NAD+/NADH ratio and bioenergetic function.
Conclusions
In this study, the sensitivity of the cytosolic free NAD+/NADH ratio towards perturbations in
extracellular glucose and lactate was assessed using an in silicomodel of hepatocarcinoma gly-
colytic flux. The model predicts that the NAD+/NADH ratio is particularly sensitive to changes
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in extracellular lactate whereby elevated concentrations, comparable to those found in a
tumour microenvironment, can result in a decrease in the NAD+/NADH ratio of up to 44.2%
after 2 hours. The model was used to investigate how changes in extracellular glucose and lac-
tate influence cancer bioenergetics through GAPDH and LDH flux, predicting that GAPDH
and LDH are most sensitive to glucose and lactate respectively. Maximal changes in the
enzyme fluxes of 318% and 716% for GAPDH and LDH are achieved, when extracellular glu-
cose and lactate concentrations are 25 mM and 40 mM respectively. Overall, the model can be
used to simulate experimentally challenging situations, such as circumventing the need to arti-
ficially alter the state of lactate equilibrium during estimation of the cytosolic free NAD+/
NADH, while providing a platform from which experimental design of extracellular substrate
manipulation can be assisted.
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